PharmAbcine Inc.
Clinical-stage biotech developing human monoclonal antibodies for various diseases.
208340 | KO
Overview
Corporate Details
- ISIN(s):
- KR7208340000
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 유성대로1689번길 70 KT대덕2연구센터 연구2동 2층, 대전광역시
- Website:
- http://pharmabcine.com/
- Sector:
- Manufacturing
Description
PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-04-28 00:00 |
기타시장안내 (개선계획 이행내역서 제출)
|
Korean | 3.0 KB | ||
| 2025-04-07 00:00 |
기타시장안내 (개선기간 종료에 따른 상장폐지 여부 결정 안내)
|
Korean | 3.1 KB | ||
| 2025-04-07 00:00 |
[기재정정]기타시장안내 (개선기간 종료에 따른 상장폐지 여부 결정 안내)
|
Korean | 6.3 KB | ||
| 2025-04-03 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 153.7 KB | ||
| 2025-03-31 00:00 |
정기주주총회결과
|
Korean | 20.7 KB | ||
| 2025-03-21 00:00 |
감사보고서제출
|
Korean | 26.0 KB | ||
| 2025-03-21 00:00 |
사업보고서 (2024.12)
|
Korean | 1.8 MB | ||
| 2025-03-14 00:00 |
주주총회소집공고
|
Korean | 182.3 KB | ||
| 2025-03-14 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.2 KB | ||
| 2025-03-14 00:00 |
주주총회소집결의
|
Korean | 10.2 KB | ||
| 2025-03-14 00:00 |
[기재정정]주주총회소집공고
|
Korean | 377.4 KB | ||
| 2024-12-12 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2024-11-14 00:00 |
분기보고서 (2024.09)
|
Korean | 1.4 MB | ||
| 2024-11-14 00:00 |
반기또는분기매출액미달사실발생
|
Korean | 5.4 KB | ||
| 2024-11-14 00:00 |
기타시장안내 (상장적격성 실질심사 사유 추가)
|
Korean | 2.9 KB |
Automate Your Workflow. Get a real-time feed of all PharmAbcine Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PharmAbcine Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PharmAbcine Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
